Certara (CERT) vs Omada Health (OMDA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Omada Health (OMDA) has outperformed Certara (CERT) over the past year, losing 10.3% versus a loss of 30.7%. Certara is the larger company by market cap ($1.32 billion vs $1.27 billion), about 1.0 times the size. On valuation, Certara trades at a lower forward P/E (22.2x vs 37.4x for Omada Health).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERT | OMDA |
|---|---|---|
| Share price | $8.64 | $20.82 |
| Market cap | $1.32B | $1.27B |
| 1-day change | -3.57% | -0.34% |
| YTD return | +1.70% | +32.38% |
| 1-year return | -30.70% | -10.34% |
| 5-year return | -76.32% | — |
| P/E ratio (TTM) | — | 86.75 |
| Forward P/E | 22.17 | 37.44 |
| EPS (TTM) | $-0.14 | $0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.12 | $26.92 |
| 52-week low | $4.45 | $10.28 |
| Distance from 52-week high | -34.15% | -22.65% |
| Analyst consensus | buy | buy |
| Avg. price target upside | -0.23% | +36.50% |
| Average volume | 3.07M | 1.38M |
| Shares outstanding | 152.54M | 61.22M |
| Employees | 1,515 | 946 |
| Sector | Technology | Health Care |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OMDA has outperformed CERT by 20.4 percentage points over the past year.
- The two companies sit in different sectors: Certara in Technology and Omada Health in Health Care.
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Technology · Computer Software: Prepackaged Software · 1,515 employees
About Omada Health
OMDA stock →Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Health Care · Medical/Nursing Services · 946 employees
CERT vs OMDA FAQ
Which is bigger, Certara or Omada Health?
Certara (CERT) is larger, with a market capitalization of $1.32B compared with $1.27B for Omada Health (OMDA).
Which stock has performed better over the past year, CERT or OMDA?
OMDA returned -10.34% over the past 12 months, compared with -30.70% for CERT (price return, excluding dividends). Past performance does not predict future results.
Are Certara and Omada Health in the same industry?
No. Certara is in the Technology sector, while Omada Health is in Health Care.